Phase II pre-operative study of ‘super-castration’ with combination Degarelix, Abiraterone, Bicalutamide and Prednisone in high-risk localized prostate cancer.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2012
This article has no abstract
Epistemonikos ID: 3e5c5daa0d510cc95ddd4d4fec45bd12d5048139
First added on: Feb 22, 2025